Annual Accounts Receivable
$9.62 B
+$2.34 B+32.15%
31 December 2023
Summary:
Novo Nordisk A/S annual accounts receivable is currently $9.62 billion, with the most recent change of +$2.34 billion (+32.15%) on 31 December 2023. During the last 3 years, it has risen by +$3.43 billion (+55.42%). NVO annual accounts receivable is now at all-time high.NVO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$9.93 B
+$805.51 M+8.83%
30 September 2024
Summary:
Novo Nordisk A/S quarterly accounts receivable is currently $9.93 billion, with the most recent change of +$805.51 million (+8.83%) on 30 September 2024. Over the past year, it has increased by +$313.87 million (+3.26%). NVO quarterly accounts receivable is now at all-time high.NVO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +3.3% |
| 3 y3 years | +55.4% | +60.5% |
| 5 y5 years | +157.5% | +165.9% |
NVO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.4% | at high | +82.6% |
| 5 y | 5 years | at high | +157.5% | at high | +165.9% |
| alltime | all time | at high | +1993.4% | at high | +2061.7% |
Novo Nordisk A/S Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.93 B(+8.8%) |
| June 2024 | - | $9.12 B(+10.7%) |
| Mar 2024 | - | $8.25 B(-14.3%) |
| Dec 2023 | $9.62 B(+32.1%) | $9.62 B(+29.1%) |
| Sept 2023 | - | $7.45 B(-16.7%) |
| June 2023 | - | $8.94 B(+21.0%) |
| Mar 2023 | - | $7.39 B(+1.6%) |
| Dec 2022 | $7.28 B(+17.6%) | $7.28 B(+20.8%) |
| Sept 2022 | - | $6.02 B(+5.1%) |
| June 2022 | - | $5.73 B(+5.4%) |
| Mar 2022 | - | $5.44 B(-12.1%) |
| Dec 2021 | $6.19 B(+35.0%) | $6.19 B(+32.8%) |
| Sept 2021 | - | $4.66 B(+11.5%) |
| June 2021 | - | $4.18 B(-5.5%) |
| Mar 2021 | - | $4.42 B(-3.6%) |
| Dec 2020 | $4.58 B(+22.7%) | $4.58 B(+19.4%) |
| Sept 2020 | - | $3.84 B(-0.9%) |
| June 2020 | - | $3.87 B(-12.8%) |
| Mar 2020 | - | $4.44 B(+19.0%) |
| Dec 2019 | $3.73 B(+7.0%) | $3.73 B(+13.2%) |
| Sept 2019 | - | $3.30 B(-6.8%) |
| June 2019 | - | $3.54 B(+9.7%) |
| Mar 2019 | - | $3.23 B(-7.5%) |
| Dec 2018 | $3.49 B(+7.4%) | $3.49 B(+21.0%) |
| Sept 2018 | - | $2.88 B(-2.0%) |
| June 2018 | - | $2.94 B(+8.9%) |
| Mar 2018 | - | $2.70 B(-16.9%) |
| Dec 2017 | $3.25 B(+12.9%) | $3.25 B(+19.4%) |
| Sept 2017 | - | $2.72 B(+1.9%) |
| June 2017 | - | $2.67 B(+9.3%) |
| Mar 2017 | - | $2.44 B(-15.1%) |
| Dec 2016 | $2.88 B(+26.9%) | $2.88 B(+17.8%) |
| Sept 2016 | - | $2.44 B(+3.7%) |
| June 2016 | - | $2.36 B(-6.1%) |
| Mar 2016 | - | $2.51 B(+10.6%) |
| Dec 2015 | $2.27 B(+6.5%) | $2.27 B(+10.9%) |
| Sept 2015 | - | $2.05 B(-4.2%) |
| June 2015 | - | $2.14 B(+0.6%) |
| Mar 2015 | - | $2.12 B(-0.3%) |
| Dec 2014 | $2.13 B(+5.5%) | $2.13 B(+15.5%) |
| Sept 2014 | - | $1.84 B(-12.5%) |
| June 2014 | - | $2.11 B(+9.2%) |
| Mar 2014 | - | $1.93 B(-4.4%) |
| Dec 2013 | $2.02 B | $2.02 B(+14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | - | $1.76 B(-8.4%) |
| June 2013 | - | $1.92 B(+5.7%) |
| Mar 2013 | - | $1.82 B(+6.4%) |
| Dec 2012 | $1.71 B(+4.9%) | $1.71 B(+1.8%) |
| Sept 2012 | - | $1.68 B(+1.0%) |
| June 2012 | - | $1.66 B(-3.1%) |
| Mar 2012 | - | $1.71 B(+5.2%) |
| Dec 2011 | $1.63 B(+7.4%) | $1.63 B(-1.4%) |
| Sept 2011 | - | $1.65 B(-9.7%) |
| June 2011 | - | $1.83 B(+6.0%) |
| Mar 2011 | - | $1.73 B(+13.9%) |
| Dec 2010 | $1.52 B(+11.6%) | $1.52 B(-2.6%) |
| Sept 2010 | - | $1.56 B(+9.5%) |
| June 2010 | - | $1.42 B(-3.8%) |
| Mar 2010 | - | $1.48 B(+8.7%) |
| Dec 2009 | $1.36 B(+9.8%) | $1.36 B(+0.2%) |
| Sept 2009 | - | $1.36 B(-0.8%) |
| June 2009 | - | $1.37 B(+15.2%) |
| Mar 2009 | - | $1.19 B(-4.1%) |
| Dec 2008 | $1.24 B(+3.7%) | $1.24 B(-6.7%) |
| Sept 2008 | - | $1.33 B(+0.7%) |
| June 2008 | - | $1.32 B(+0.9%) |
| Mar 2008 | - | $1.31 B(+9.5%) |
| Dec 2007 | $1.19 B(+30.6%) | $1.19 B(+1.0%) |
| Sept 2007 | - | $1.18 B(+7.5%) |
| June 2007 | - | $1.10 B(+13.3%) |
| Mar 2007 | - | $970.00 M(+6.2%) |
| Dec 2006 | $913.47 M(+20.4%) | $913.47 M(+6.8%) |
| Sept 2006 | - | $855.00 M(-1.3%) |
| June 2006 | - | $866.27 M(+9.2%) |
| Mar 2006 | - | $793.12 M(+4.5%) |
| Dec 2005 | $759.00 M(+2.0%) | $759.00 M(-1.4%) |
| Sept 2005 | - | $769.57 M(+1.5%) |
| June 2005 | - | $757.91 M(+2.4%) |
| Mar 2005 | - | $740.41 M(-0.5%) |
| Dec 2004 | $744.27 M(+15.2%) | $744.27 M(+18.3%) |
| Sept 2004 | - | $629.15 M(+0.1%) |
| June 2004 | - | $628.31 M(+1.6%) |
| Mar 2004 | - | $618.59 M(-4.2%) |
| Dec 2003 | $646.02 M(+20.4%) | $646.02 M(+20.4%) |
| Dec 2002 | $536.54 M(+16.8%) | $536.54 M(+16.8%) |
| Dec 2001 | $459.38 M(-21.7%) | $459.38 M(-21.7%) |
| Dec 2000 | $587.05 M(-20.7%) | $587.05 M(-20.7%) |
| Dec 1999 | $740.38 M(-17.2%) | $740.38 M(-17.2%) |
| Dec 1998 | $893.87 M | $893.87 M |
FAQ
- What is Novo Nordisk A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly accounts receivable year-on-year change?
What is Novo Nordisk A/S annual accounts receivable?
The current annual accounts receivable of NVO is $9.62 B
What is the all time high annual accounts receivable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual accounts receivable is $9.62 B
What is Novo Nordisk A/S quarterly accounts receivable?
The current quarterly accounts receivable of NVO is $9.93 B
What is the all time high quarterly accounts receivable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly accounts receivable is $9.93 B
What is Novo Nordisk A/S quarterly accounts receivable year-on-year change?
Over the past year, NVO quarterly accounts receivable has changed by +$313.87 M (+3.26%)